Novel maternal autoantibodies in autism spectrum disorder: Implications for screening and diagnosis.

Mazón-Cabrera R, Liesenborgs J, Brône B, Vandormael P, Somers V

Open source

DOI
10.3389/fnins.2023.1067833
Published
2023
Container
Frontiers in neuroscience
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fnins.2023.1067833,
  title = {Novel maternal autoantibodies in autism spectrum disorder: Implications for screening and diagnosis.},
  author = {Mazón-Cabrera R and Liesenborgs J and Brône B and Vandormael P and Somers V},
  year = {2023},
  journal = {Frontiers in neuroscience},
  doi = {10.3389/fnins.2023.1067833},
  url = {https://doi.org/10.3389/fnins.2023.1067833}
}

RIS

TY  - JOUR
TI  - Novel maternal autoantibodies in autism spectrum disorder: Implications for screening and diagnosis.
AU  - Mazón-Cabrera R
AU  - Liesenborgs J
AU  - Brône B
AU  - Vandormael P
AU  - Somers V
PY  - 2023
JO  - Frontiers in neuroscience
DO  - 10.3389/fnins.2023.1067833
UR  - https://doi.org/10.3389/fnins.2023.1067833
ER  - 

APA

R, M., J, L., B, B., P, V., & V, S. (2023). Novel maternal autoantibodies in autism spectrum disorder: Implications for screening and diagnosis.. Frontiers in neuroscience. https://doi.org/10.3389/fnins.2023.1067833

Source records